CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J’s

By Michael Erman

Dec 16 (Reuters) – The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson & Johnson’s (JNJ.N) shot, due to rare but sometimes fatal cases of blood-clotting.

The CDC’s move came after its Advisory Committee on Immunization voted unanimously to make the recommendation in favour of the vaccines made by Moderna Inc (MRNA.O) and Pfizer (PFE.N)/BioNTech (22UAy.DE) over the J&J shot.

More Here:

https://www.reuters.com/business/healthcare-pharmaceuticals/blood-clot-rates-after-jj-vaccine-higher-than-previous-estimates-cdc-advisers-2021-12-16/

Facebooktwitterredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading